Nitazoxanide: a new broad spectrum antiparasitic agent - PubMed (original) (raw)
Review
Nitazoxanide: a new broad spectrum antiparasitic agent
Clinton A White Jr. Expert Rev Anti Infect Ther. 2004 Feb.
Abstract
Nitazoxanide (Alinia, Romark Laboratories) was synthesized based on the structure of niclosamide. In vitro studies have demonstrated activity against a broad range of parasites as well as some bacteria. Three controlled trials demonstrated efficacy in cryptosporidiosis, however, the efficacy in advanced AIDS patients (CD4 cell counts = 50) at approved doses was limited. Trials have also demonstrated efficacy comparable to metronidazole (Flagyl, GD Searle and Co.) in giardiasis with fewer side effects. Nitazoxanide is also effective versus intestinal helminths and tapeworms as well as in chronic fascioliasis. Side effects in clinical trials have been similar to placebo. Nitazoxanide is the first agent proven to be effective in cryptosporidiosis. It has also proven efficacy in giardiasis. Nitazoxanide is efficacious again intestinal helminths. Additional indications may be developed in the future.
Similar articles
- Nitazoxanide: an important advance in anti-parasitic therapy.
White AC Jr. White AC Jr. Am J Trop Med Hyg. 2003 Apr;68(4):382-3. Am J Trop Med Hyg. 2003. PMID: 12875283 No abstract available. - Cryptosporidium and Giardia: treatment options and prospects for new drugs.
Rossignol JF. Rossignol JF. Exp Parasitol. 2010 Jan;124(1):45-53. doi: 10.1016/j.exppara.2009.07.005. Epub 2009 Jul 24. Exp Parasitol. 2010. PMID: 19632225 - Epidemiology and control of intestinal parasites with nitazoxanide in children in Mexico.
Diaz E, Mondragon J, Ramirez E, Bernal R. Diaz E, et al. Am J Trop Med Hyg. 2003 Apr;68(4):384-5. Am J Trop Med Hyg. 2003. PMID: 12875284 - Nitazoxanide treatment for giardiasis and cryptosporidiosis in children.
Bailey JM, Erramouspe J. Bailey JM, et al. Ann Pharmacother. 2004 Apr;38(4):634-40. doi: 10.1345/aph.1D451. Epub 2004 Feb 27. Ann Pharmacother. 2004. PMID: 14990779 Review. - Nitazoxanide: a review of its use in the treatment of gastrointestinal infections.
Anderson VR, Curran MP. Anderson VR, et al. Drugs. 2007;67(13):1947-67. doi: 10.2165/00003495-200767130-00015. Drugs. 2007. PMID: 17722965 Review.
Cited by
- Comparative efficacy and safety of anti-cryptosporidial agents: an in vitro study on nitazoxanide, halofuginone lactate, KDU731, and paromomycin against Cryptosporidium parvum.
Whitta STG, Lamont B, Suwanarusk R, Russell BM, Muhsin-Sharafaldine MR. Whitta STG, et al. Front Microbiol. 2024 Oct 4;15:1463457. doi: 10.3389/fmicb.2024.1463457. eCollection 2024. Front Microbiol. 2024. PMID: 39430109 Free PMC article. - Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs".
Li Y, Huo S, Yin Z, Tian Z, Huang F, Liu P, Liu Y, Yu F. Li Y, et al. mBio. 2024 May 8;15(5):e0017524. doi: 10.1128/mbio.00175-24. Epub 2024 Mar 29. mBio. 2024. PMID: 38551343 Free PMC article. - Anthelmintic efficacy of nitazoxanide in dogs naturally infected with Toxocara canis.
Yuan Y, Zhao Q, Suo X, Liu X, Hao Z. Yuan Y, et al. Parasitol Res. 2024 Mar 16;123(3):162. doi: 10.1007/s00436-024-08168-3. Parasitol Res. 2024. PMID: 38492070 - Natural History of Influenza B Virus-Current Knowledge on Treatment, Resistance and Therapeutic Options.
Din GU, Hasham K, Amjad MN, Hu Y. Din GU, et al. Curr Issues Mol Biol. 2023 Dec 26;46(1):183-199. doi: 10.3390/cimb46010014. Curr Issues Mol Biol. 2023. PMID: 38248316 Free PMC article. Review. - New nitazoxanide derivatives: design, synthesis, biological evaluation, and molecular docking studies as antibacterial and antimycobacterial agents.
Saleh M, Mostafa YA, Kumari J, Thabet MM, Sriram D, Kandeel M, Abdu-Allah HHM. Saleh M, et al. RSC Med Chem. 2023 Oct 10;14(12):2714-2730. doi: 10.1039/d3md00449j. eCollection 2023 Dec 13. RSC Med Chem. 2023. PMID: 38107181 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials